References

1. Mullol J, Alobid I, Mariño-Sánchez F, Quintó L, de Haro J, Bernal-Sprekelsen M, et al. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open. 2012;2(6).
2. Damm M, Temmel A, Welge-Lüssen A, Eckel HE, Kreft MP, Klussmann JP, et al. [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. HNO. 2004 Feb;52(2):112-20.
3. Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, et al. More than just smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. medRxiv. 2020:2020.05.04.20090902.
4. Philpott C. Coronavirus: loss of smell and taste reported as early symptoms of COVID-19. The Conversation. 2020.
5. McNeill E, Ramakrishnan Y, Carrie S. Diagnosis and management of olfactory disorders: survey of UK-based consultants and literature review. J Laryngol Otol. 2007 Aug;121(8):713-20.
6. Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinology. 2017 Jun 17.
7. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A, et al. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol. 2020 Aug.
8. Philpott CM, Boak D. The impact of olfactory disorders in the United kingdom. Chem Senses. 2014 Oct;39(8):711-8.
9. Erskine SE, Philpott CM. An unmet need: Patients with smell and taste disorders. Clin Otolaryngol. 2020 Mar;45(2):197-203.
10. Addison A, Philpott CM. A systematic review of therapeutic options for non-conductive olfactory dysfunction. The Otorhinolarnyngologist. 2018;11(2):61-71.
11. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2819-25.
12. Philpott CM. Smell and Taste Disorders in the UK: First experiences with a specialised smell and taste outpatient clinic. Bulletin of the Royal College of Surgeons of England. 2014;96:156-59.
13. Ball S, Boak D, Dixon J, Carrie S, Philpott C. Barriers to accessing healthcare in patients with olfactory and gustatory disorders. Authorea. 2020.
14. Langstaff L, Pradhan N, Clark A, Boak D, Salam M, Hummel T, et al. Validation of the olfactory disorders questionnaire for English-speaking patients with olfactory disorders. Clin Otolaryngol. 2019 Sep;44(5):715-28.
15. Moran DT, Jafek BW, Eller PM, Rowley JC. Ultrastructural histopathology of human olfactory dysfunction. Microsc Res Tech. 1992 Oct;23(2):103-10.
16. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1064-70.
17. Whitcroft KL, Merkonidis C, Cuevas M, Haehner A, Philpott C, Hummel T. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia. Rhinology. 2016;54:368-74.
18. Philpott CM, Erskine SE, Clark A, Leeper A, Salam M, Sharma R, et al. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders. Clin Otolaryngol. 2017 Dec;42(6):1295-302.
19. Whitcroft KL, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients. Clin Otolaryngol. 2017 Jun;42(3):557-63.